在复发性质母细胞瘤中服用贝瓦齐祖马布后,不增强的病变的放射学分析
Takahiro Sanada1,2, Takeshi Shimizu1, Yoshiko Okita3,4,5
1Department of Neurosurgery, Asahikawa Medical University, Asahikawa 078-8510, Japan.
Bioengineering (Basel, Switzerland)
|January 28, 2026
概括
在贝瓦齐祖马布 (BEV) 治疗后成为非对比增强瘤 (nCET) 的对比增强瘤 (CET) 的放射性特征可以在质母细胞瘤 (GBM) 中识别nCET. 这种方法对改善GBM患者的nCET检测有希望.
科学领域:
- 放射学 放射学是一门学科.
- 医疗成像医学成像
- 在瘤学瘤学.
背景情况:
- 质母细胞瘤 (GBM) 是一种具有攻击性的脑瘤.
- 识别非对比增强瘤 (nCET) 对于治疗评估至关重要.
- 贝瓦西祖马布 (BEV) 可以改变GBM的对比度增强模式.
研究的目的:
- 探索用于识别nCET的放射性特征.
- 分析在BEV治疗后转化为nCET的对比度增强瘤 (CET) 的区域.
- 开发和验证nCET检测的预测模型.
主要方法:
- 用贝瓦西祖马布 (BEV) 治疗的复发性GBM (rGBM) 和新诊断的GBM (nGBM) 队列中的放射性特征的分析.
- 使用加多增强的T1加权成像 (T1Gd),T2加权成像 (T2WI),FLAIR和11C-氨酸正子辐射断层扫描 (Met-PET).
- 使用显著的放射性特征开发了一个预测模型,并评估了它的性能.
主要成果:
- 在BEV队列中确定了37个显著的放射性特征,在Met-PET队列中确定了46个显著的放射性特征.
- 该预测模型在BEV队列中获得了高精度 (AUC = 0.93),在Met-PET队列中获得了中度精度 (AUC = 0.74).
- 放射性特征在nGBM中有效地可视化了nCET,表明了它们的实用性.
结论:
- 在BEV处理后转化为nCET的CET区域的放射性特征包含了用于nCET识别的有价值信息.
- 开发的模型显示了在GBM中改善nCET检测的潜力.
- 进一步的研究可以完善用于GBM表征的放射性方法.
相关概念视频
Self-Evaluation: Self-Enhancement and Self-Verification
5.8K
Social psychologists have documented that feeling good about ourselves and maintaining positive self-esteem is a powerful motivator of human behavior (Tavris & Aronson, 2008). In the United States, members of the predominant culture typically think very highly of themselves and view themselves as good people who are above average on many desirable traits (Ehrlinger, Gilovich, & Ross, 2005). Often, our behavior, attitudes, and beliefs are affected when we experience a threat to our...
5.8K
Bioavailability Enhancement: Drug Solubility Enhancement
255
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
255
Bioavailability Enhancement: Drug Permeability Enhancement
197
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
197
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
207
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
207
Additional Routes of Drug Administration
4.9K
Choosing the appropriate route of drug administration is significantly influenced by two key factors: the therapeutic objectives and the inherent properties of the drug being used.
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
4.9K
Routes of Drug Administration: Enteral
6.4K
Medications can be administered through the enteral route using liquids, capsules, or tablets.
Enteral administration involves drug administration via the mouth in two ways: orally or sublingually.
Unlike sublingually drugs, drugs that are taken orally pass through the gastrointestinal (GI) tract and get metabolized by the liver. Once metabolized, the drug is absorbed into the systemic circulation, reaching different body parts via the bloodstream. However, while passing through the stomach,...
Enteral administration involves drug administration via the mouth in two ways: orally or sublingually.
Unlike sublingually drugs, drugs that are taken orally pass through the gastrointestinal (GI) tract and get metabolized by the liver. Once metabolized, the drug is absorbed into the systemic circulation, reaching different body parts via the bloodstream. However, while passing through the stomach,...
6.4K


